951753-87-0 (5-异硫氰酰基-3-(三氟甲基)吡啶-2-氰基,5-Isothiocyanato-3-(trifluoromethyl)-picolinonitrile)

CAS号:
951753-87-0
中文名称:
5-异硫氰酰基-3-(三氟甲基)吡啶-2-氰基
英文名称:
5-Isothiocyanato-3-(trifluoromethyl)-picolinonitrile
分子式:
C8H2F3N3S
分子量:
229.181789875031

5-异硫氰酰基-3-(三氟甲基)吡啶-2-氰基(951753-87-0)名称与标识符

名称

中文别名:
5-异硫氰酰基-3-(三氟甲基)吡啶-2-氰基;5-异硫氰酸基-3-(三氟甲基)-2-吡啶甲腈;
英文别名:
5-isothiocyanato-3-(trifluoromethyl)picolinonitrile;5-Isothiocyanato-3-(trifluoromethyl)2-cyanopyridine;5-Isothiocyanato-3-(trifluoromethyl)-2-pyridinecarbonitrile (ACI);2-Cyano-5-(isothiocyanato)-3-(trifluoromethyl)pyridine;MFCD18382742;(5-Isothiocyanato-3-(trifluoromethyl)picolinonitrile);AT17809;951753-87-0;5-isothiocyanato-3-(trifluoromethyl)pyridine-2-carbonitrile;AS-84072;SCHEMBL908840;SY129080;5-Isothiocyanato-3-(trifluoromethyl)-2-pyridinecarbonitrile;DB-203271;AC-31087;5-Isothiocyanato-3-(trifluoromethyl)-picolinonitrile;5-isothiocyanato-3-trifluoromethylpyridine-2-carbonitrile;

标识符

MDL:
MFCD18382742
InChIKey:
NQNLQGJLAVDALO-UHFFFAOYSA-N
Inchi:
1S/C8H2F3N3S/c9-8(10,11)6-1-5(14-4-15)3-13-7(6)2-12/h1,3H
SMILES:
N#CC1C(C(F)(F)F)=CC(N=C=S)=CN=1

5-异硫氰酰基-3-(三氟甲基)吡啶-2-氰基(951753-87-0)物化性质

实验特性

  • 溶解度 : 几乎不溶 (0.053 g/L) (25 ºC),
  • 密度 : 1.41±0.1 g/cm3 (20 ºC 760 Torr),

计算特性

  • 精确分子量 : 228.99215274g/mol
  • 氢键供体数量 : 0
  • 氢键受体数量 : 7
  • 可旋转化学键数量 : 1
  • 同位素质量 : 228.99215274g/mol
  • 重原子数量 : 15
  • 复杂度 : 326
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 3.2
  • 拓扑分子极性表面积 : 81.1Ų

5-异硫氰酰基-3-(三氟甲基)吡啶-2-氰基(951753-87-0)推荐厂家 更多厂家(29)

5-异硫氰酰基-3-(三氟甲基)吡啶-2-氰基(951753-87-0)合成路线

合成路线:1 步
反应条件:
参考文献:
Spirocyclic Thiohydantoin Antagonists of F877L and Wild-Type Androgen Receptor for Castration-Resistant Prostate Cancer
Zhang, Zhuming ; Connolly, Peter J.; Trabalon Escolar, Luis; Rocaboy, Christian; Pande, Vineet; et al, ACS Medicinal Chemistry Letters, 2021, 12(8), 1245-1252
合成路线:1 步
反应条件:
参考文献:
Discovery of JNJ-63576253: A Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC)
Zhang, Zhuming ; Connolly, Peter J.; Lim, Heng Keang; Pande, Vineet; Meerpoel, Lieven; et al, Journal of Medicinal Chemistry, 2021, 64(2), 909-924
合成路线:1 步
反应条件:
参考文献:
Process for preparing apalutamide
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of substituted thiohydantoin derivatives as androgen receptor antagonists
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Processes for the preparation of Apalutamide and intermediates thereof
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Synthesis of thiohydantoins
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of hydantoins as androgen receptor modulators for the treatment of prostate cancer and other androgen receptor-associated diseases.
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Androgen receptor-regulator hydantoin derivatives and its application
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of thiodiazaspiro compound and its intermediates
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation method of apalutamide and its intermediates
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Pyridylthiourea derivatives and preparation method and application thereof in preparing apalutamide
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of 5-isothiocyanato-3-(trifluoromethyl)-2-pyridinecarbonitrile
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Discovery of pyridine tetrahydroisoquinoline thiohydantoin derivatives with low blood-brain barrier penetration as the androgen receptor antagonists
Xu, Xi; Du, Qianming; Meng, Ying; Li, Zhiyu; Wu, Hongxi; et al, European Journal of Medicinal Chemistry, 2020, 192,
合成路线:1 步
反应条件:
参考文献:
Synthesis of Hydantoin Androgen Receptor Antagonists and Study on Their Antagonistic Activity
Ma, Longjun; Zhou, Yan; Yang, Dehua; Wang, Ming-Wei; Lu, Wei; et al, Molecules, 2022, 27(18),
合成路线:1 步
反应条件:
参考文献:
Preparation method of 5-isothiocyanato-3-trifluoromethyl-2-cyanopyridine
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of aromatic ring and cyclic lactide-containing thiohydantoin compound and its application as androgen receptor antagonists for the treatment of prostate cancer
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Design, synthesis and biological evaluation of novel thiohydantoin derivatives as potent androgen receptor antagonists for the treatment of prostate cancer
Wang, Ao; Wang, Yawan; Meng, Xin; Yang, Yushe, Bioorganic & Medicinal Chemistry, 2021, 31,
合成路线:1 步
反应条件:
参考文献:
Nitrogen heterocycles as androgen receptor and phosphodiesterase dual inhibitor
, World Intellectual Property Organization, , ,